Cresco Labs Opens 33rd Florida Sunnyside in Jacksonville, 70th Store Nationwide

Rhea-AI Summary

Cresco Labs opens second Sunnyside dispensary in Jacksonville, Florida, bringing the total store count to 33 in the state and 70 nationally.

Positive

• Cresco Labs continues to expand its footprint in Florida, a market with opportunities for material value.
• The new dispensary is located in an area of significant development in Riverside, Jacksonville, with high population density.
• The store offers a diverse assortment of cannabis products at fair pricing and has online ordering available.

Negative

• None.

CHICAGO--(BUSINESS WIRE)-- Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of a second Sunnyside in Jacksonville, Florida. Located at 2725 College St., the new store joins its sister location in Jacksonville Beach in providing patients with greater access to best-in-class cannabis products from the Company’s branded portfolio. Today’s opening brings Cresco Labs’ store count to 33 dispensaries in Florida and 70 locations nationally.

Cresco Labs opened a new Sunnyside dispensary at 2725 College St. in Jacksonville, Florida. There are 33 Sunnyside locations throughout Florida. (Photo: Business Wire)

“We’ll continue to increase our footprint in the right markets, such as Florida, where we continue to see opportunities to drive material value. We’re bringing our bestselling branded products to our stores and expanding access to cannabis to more patients—it’s a win-win scenario,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs. “Jacksonville has significant population density, and our newest dispensary is in the heart of Riverside, where there is tremendous development taking place. We look forward to serving more patients in the region through our two stores.”

Sunnyside Jacksonville (Riverside) is dedicated to helping qualified patients unlock all the benefits that cannabis can provide. The store has one of the largest, most diverse assortments among Florida dispensaries, offering a suite of accessories and products at fair pricing and great offers, like flower, pre-rolls, vape cartridges, disposable vape pens, concentrates, edibles and topicals from the Company’s branded portfolio that includes Cresco, Supply, One Plant, FloraCal, Good News, Remedi and Sunnyside.

Patients can place orders today both in store and online at www.sunnyside.shop. Dispensary hours are Sunday, 9 AM to 6 PM, and Monday through Saturday, 9 AM to 8 PM.

For more information about Cresco Labs, visit www.crescolabs.com. To learn more about Sunnyside, visit www.sunnyside.shop.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230912928007/en/

Media

Jason Erkes, Cresco Labs

Chief Communications Officer

press@crescolabs.com

312-953-2767



Investors

Megan Kulick, Cresco Labs

SVP, Investor Relations

investors@crescolabs.com



General Cresco Labs Inquiries

312-929-0993

info@crescolabs.com

Source: Cresco Labs